Continuation versus discontinuation of intravenous oxytocin in the active phase of labour
- PMID: 39611412
- PMCID: PMC11605788
- DOI: 10.1002/14651858.CD015995
Continuation versus discontinuation of intravenous oxytocin in the active phase of labour
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of discontinuing intravenous oxytocin stimulation in pregnant women during the active phase of induced or augmented labour.
Copyright © 2024 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Conflict of interest statement
Sidsel Boie is an author/co‐author on two of the possibly eligible trials (Boie 2021; Bor 2016). She will not be involved in any decisions relating to this review: eligibility assessment, risk of bias assessment, data extraction and GRADE assessment will be carried out by other members of the team who are not directly involved in the trials.
Niels Ulbjerg is a co‐author on one of the possibly eligible trials (Boie 2021). He will not be involved in any decisions relating to this review: eligibility assessment, risk of bias assessment, data extraction and GRADE assessment will be carried out by other members of the team who are not directly involved in the trial.
Jim Thornton has no potential conflicts of interest to declare.
Irene de Graaf has no potential conflicts of interest to declare.
Camille Ray is a co‐author on one of the possibly eligible trials (Girault 2023). She will not be involved in any decisions relating to this review: eligibility assessment, risk of bias assessment, data extraction and GRADE assessment will be carried out by other members of the team who are not directly involved in the trial.
Julie Glavind is a co‐author on one of the possibly eligible trials (Boie 2021). She will not be involved in any decisions relating to this review: eligibility assessment, risk of bias assessment, data extraction and GRADE assessment will be carried out by other members of the team who are not directly involved in the trial.
Francois Goffinet was involved in one of the possibly eligible trials (Girault 2023). He will not be involved in any decisions relating to this review: eligibility assessment, risk of bias assessment, data extraction and GRADE assessment will be carried out by other members of the team who are not directly involved in the trial.
Aude Girault is an author on one of the possibly eligible trials (Girault 2023). She will not be involved in any decisions relating to this review: eligibility assessment, risk of bias assessment, data extraction and GRADE assessment will be carried out by other members of the team who are not directly involved in the trial.
Pinar Bor is an author/co‐author on two of the possibly eligible trials (Boie 2021; Bor 2016). She will not be involved in any decisions relating to this review: eligibility assessment, risk of bias assessment, data extraction and GRADE assessment will be carried out by other members of the team who are not directly involved in the trials.
References
Additional references
Alfirevic 2016
-
- Alfirevic Z, Keeney E, Dowswell T, Welton NJ, Medley N, Dias S, et al. Which method is best for the induction of labour? A systematic review, network meta-analysis and cost-effectiveness analysis. Health Technology Assessment (Winchester, England) 2016;20(65):1-584. [DOI: 10.3310/hta20650] - DOI - PMC - PubMed
Bliddal 2018
Boie 2018
Boie 2021
Bor 2016
Budden 2014
Caughey 2014
Clark 2009
Covidence [Computer program]
-
- Covidence. Version accessed 12 June 2024. Melbourne, Australia: Veritas Health Innovation, 2015. Available at covidence.org.
Cox 1987
Daly 2020
Dencker 2010
Dos Santos 2018
-
- Dos Santos F, Drymiotou S, Antequera Martin A, Mol BW, Gale C, Devane D, et al. Development of a core outcome set for trials on induction of labour: an international multistakeholder Delphi study. British Journal of Obstetrics and Gynaecology 2018;125(13):1673-80. [DOI: 10.1111/1471-0528.15397] - DOI - PubMed
Fernández 2012
Girault 2023
Glanville 2019
-
- Glanville J, Foxlee R, Wisniewski S, Noel-Storr A, Edwards M, Dooley G. Translating the Cochrane EMBASE RCT filter from the Ovid interface to Embase.com: a case study. Health Information and Libraries Journal 2019;36:264-77. [DOI: 10.1111/hir.12269] - DOI - PubMed
Glanville 2020
GRADE Handbook
-
- Schünemann H, Brożek J, Guyatt G, Oxman A, editors. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.
GRADEpro GDT [Computer program]
-
- GRADEpro GDT. Version accessed 12 June 2024. Hamilton (ON): McMaster University (developed by Evidence Prime), 2021. Available at gradepro.org.
Grotegut 2011
Higgins 2011
-
- Higgins JPT, Altman DG, Sterne JAC (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.
Higgins 2023
-
- Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023. Available from training.cochrane.org/handbook.
Hodnett 1987
ISMP 2024
-
- ISMP Medication Safety Alert. https://www.ismp.org/sites/default/files/attachments/2024-01/20240111.pdf.
Lefebvre 2024
-
- Lefebvre C, Glanville J, Briscoe S, Littlewood A, Marshall C, Metzendorf M-I, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated September 2024). Cochrane, 2024. Available from training.cochrane.org/handbook.
NICE 2021
-
- National Institute for Health and Care Excellence (NICE). Inducing labour. Available online at www.nice.org.uk/guidance/ng207 (accessed 12 June 2024) 2021. [ISBN: 978-1-4731-4327-2]
NICE 2023
-
- National Institute for Health and Care Excellence (NICE). Intrapartum care. https://www.nice.org.uk/guidance/ng235 (accessed 12 June 2024) 2023. [ISBN: 978-1-4731-5384-4]
Oláh 2015
-
- Oláh Karl SJ, Steer Philip J. The use and abuse of oxytocin. The Obstetrician & Gynaecologist 2015;4:265-71. [DOI: 10.1111/tog.12222] - DOI
Phaneuf 1998
Phaneuf 2000
-
- Phaneuf S, Rodriguez Linares B, TambyRaja RL, MacKenzie IZ, Lopez Bernal A. Loss of myometrial oxytocin receptors during oxytocin-induced and oxytocin-augmented labour. Journal of Reproduction and Fertility 2000;120(1):91-7. - PubMed
RevMan 2024 [Computer program]
-
- Review Manager. Version 7.12.0. The Cochrane Collaboration, 2024. Available at revman.cochrane.org.
Simpson 2009
-
- Simpson KR, Knox GE. Oxytocin as a high alert medication: implications for perinatal patient safety. American Journal of Maternal/Child Nursing 2009;34(1):8-15. [DOI: 10.1097/01.NMC.0000343859.62828.ee] - DOI - PubMed
Steer 1985
-
- Steer PJ, Carter MC, Choong K, Hanson M, Gordon AJ, Pradhan P. A multicentre prospective randomized controlled trial of induction of labour with an automatic closed-loop feedback controlled oxytocin infusion system. British Journal of Obstetrics and Gynaecology 1985;92(11):1127-33. - PubMed
SWiM
-
- Synthesis Without Meta-Analysis - SWiM guidelines. Available at https://swim.sphsu.gla.ac.uk/ (accessed 13 June 2024).
Tribe 2012
-
- Tribe RM, Crawshaw SE, Seed P, Shennan AH, Baker PN. Pulsatile versus continuous administration of oxytocin for induction and augmentation of labor: two randomized controlled trials. American Journal of Obstetrics and Gynecology 2012;206(3):230.e1-e8. [DOI: 10.1016/j.ajog.2011.11.001] - DOI - PubMed
WHO 2022
-
- World Health Organization. WHO recommendations on induction of labour, at or beyond term. Available at https://www.who.int/publications/i/item/9789241501156 (accessed 12 June 2024). [LICENCE: CC BY-NC-SA 3.0 IGO]
MeSH terms
Substances
LinkOut - more resources
Full Text Sources